McNeil
Also known as: Global Medical Affairs & Clinical Research, McNeil AB, Sweden | MCNEIL | Mc Neil AB | MCNEIL CONS | MCNEIL CONSUMER | McNeil Consumer Healthcare Division of Mc-Neil-PPC, Inc. | McNeil Consumer Healthcare USA | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | MCNEIL PED | McNeil UK
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1999First marketed drug
Sep 12, 1945First NDA
Sep 12, 1945Last known activity
Jun 1, 2017
Timeline
1930s
- Jan 1, 1933
McNeil— Founded
1950s
- Jan 1, 1959
Johnson and Johnson— Acquired By
1970s
- Dec 27, 1974
carbinoxamine maleate— NDA Organization
1980s
- May 16, 1986
ibuprofen— NDA Secondary Org
1990s
- Oct 31, 1991
pseudoephedrine— Marketing Organization
Drugs by trial phase (33 distinct, 99 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Approved for
- Acne Vulgaris
- Anaphylaxis
- Angioedema
- Arthritis
- Back Pain
- Common Cold
- Conjunctivitis, Allergic
- Eye Infections, Bacterial
- Fever
- Gingivitis
- Headache
- Inflammation
- Keratosis, Seborrheic
- Rhinitis, Allergic, Perennial
- Rhinitis, Allergic, Seasonal
- Rhinitis, Vasomotor
- Skin Diseases, Bacterial
- Sleep Initiation and Maintenance Disorders
- Urticaria
Studied for
- Alcohol Drinking
- Alcohol-Related Disorders
- Anemia, Sickle Cell
- Ankle Injuries
- Anorexia
- Anorexia Nervosa
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Bipolar Disorder
- Chemical and Drug Induced Liver Injury
- Collagen Diseases
- Common Cold
- Cystic Fibrosis
- Diarrhea
- Disease
- Drug-Related Side Effects and Adverse Reactions
- Dyspepsia
- Enuresis
- Fatigue
- Fibrosis
- Headache
- Hemorrhage
- Hyperkinesis
- Hypersensitivity
- Liver Neoplasms
- Lower Urinary Tract Symptoms
- Malabsorption Syndromes
- Metrorrhagia
- Mucositis
- Muscle Cramp
- Myalgia
- Nocturnal Enuresis
- Osteoarthritis
- Osteoarthritis, Hip
- Osteoarthritis, Knee
- Osteoporosis
- Prostatitis
- Respiratory Tract Infections
- Rheumatic Diseases
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Spasm
- Sprains and Strains
- Steatorrhea
- Stomatitis
- Tobacco Use Disorder
- Toothache
- Urinary Incontinence
- Urination Disorders
Marketed drugs (10)
Recent trials (50)
- NCT02911961CollaboratorPhase 4Jun 1, 2017
- NCT03130179Lead sponsorPhase 1Mar 31, 2017
- NCT02660372Study directorPhase 3Feb 1, 2016
- NCT02355665CollaboratorPhase 3Jan 1, 2015
- NCT02355665Study directorPhase 3Jan 1, 2015
- NCT02355665Lead sponsorPhase 3Jan 1, 2015
- NCT02320708Study directorPhase 2Dec 1, 2014
- NCT02209181Lead sponsorPhase 2Aug 1, 2014
- NCT02209181Study directorPhase 2Aug 1, 2014
- NCT01960114Lead sponsorPhase 2Oct 1, 2013
- NCT01960114Study directorPhase 2Oct 1, 2013
- NCT01744106CollaboratorPhase 3Nov 1, 2012
- NCT01555476Lead sponsorPhase 1Feb 1, 2012
- NCT01555476Study directorPhase 1Feb 1, 2012
- NCT01476683Lead sponsorPhase 1Dec 1, 2011
Details
- Founded
- Philadelphia, PA, US Jan 1, 1933
- First NDA
- Sep 12, 1945
- Last known activity
- Jun 1, 2017